Engineered FGF-2 expression induces glandular epithelial hyperplasia in the murine prostatic dorsal lobeKONNO-TAKAHASHI, Naoko; TAKEUCHI, Takumi; NISHIMATSU, Hiroaki et al.European urology. 2004, Vol 46, Num 1, pp 126-132, issn 0302-2838, 7 p.Article

Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutantMUTO, Satoru; AIBA, Atsu; HARRIS, Peter C et al.Human molecular genetics (Print). 2002, Vol 11, Num 15, pp 1731-1742, issn 0964-6906Article

Identification of toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinomaMORIKAWA, Teppei; SUGIYAMA, Akira; KUME, Haruki et al.Clinical cancer research. 2007, Vol 13, Num 19, pp 5703-5709, issn 1078-0432, 7 p.Article

Signet-ring cell carcinoma of the urinary bladder associated with transitional cell carcinoma of the right ureterKUME, Haruki; KANAI, Yae; TOBISU, Ken-Ichi et al.Scandinavian journal of urology and nephrology. 2000, Vol 34, Num 4, pp 278-279, issn 0036-5599Article

Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy : Urological OncologyOCHIAI, Atsushi; OKIHARA, Koji; KAMOI, Kazumi et al.BJU international (Papier). 2013, Vol 111, Num 6, pp 928-933, issn 1464-4096, 6 p.Article

Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinomaYAMADA, Daisuke; KIKUCHI, Shinji; KANAI, Yae et al.International journal of cancer. 2006, Vol 118, Num 4, pp 916-923, issn 0020-7136, 8 p.Article

The prognostic value of E-cadherin, α-, β-, and γ-catenin in urothelial cancer of the upper urinary tract. CommentaryKASHIBUCHI, Keishi; TOMITA, Kyoichi; SCHALKEN, Jack A et al.European urology. 2006, Vol 49, Num 5, pp 839-845, issn 0302-2838, 7 p.Article